Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays

Vaccine

Volumn 24, Issue 8, 2006, Pages 1087-1094

  Hofmann Lehmann, Regina ^a   Tandon, Ravi ^a   Boretti, Felicitas S ^a   Meli, Marina L ^a   Willi, Barbara ^a   Cattori, Valentino ^a   Gomes Keller, Maria A ^a   Ossent, Pete ^a   Golder, Matthew C ^b   Flynn, J Norman ^b,c   Lutz, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

FeLV vaccines; Plasma viral RNA load; TaqMan real time RT PCR

Indexed keywords

ANTIGEN; EURIFEL; FELINE LEUKEMIA VIRUS VACCINE; GAG PROTEIN; INACTIVATED VIRUS VACCINE; LIVE VACCINE; POL PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANARYPOX VIRUS; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIREMIA; VIRUS ISOLATION; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEUKEMIA VIRUS, FELINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VACCINATION; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

EID: 32044464281     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.010     Document Type: Article

References (45)

1. W.F. Jarrett, E.M. Crawford, W.M. Martin, and F. Davie A virus-like particle associated with leukaemia (lymphosarcoma) Nature 202 1964 567 568
2. E.A. Hoover, and J.I. Mullins Feline leukemia virus infection and diseases J Am Vet Med Assoc 199 1991 1287 1297
3. C.M. Leutenegger, R. Hofmann-Lehmann, C. Riols, M. Liberek, G. Worel, and P. Lups Viral infections in free-living populations of the European wildcat J Wildl Dis 35 4 1999 678 686
4. D. Onions Animal models: lessons from feline and bovine leukaemia virus infections Leuk Res 9 1985 709 711
5. T. Miyazawa Infections of feline leukemia virus and feline immunodeficiency virus Front Biosci 7 2002 504 518
6. H. Lutz, N. Pedersen, J. Higgins, U. Hubscher, F.A. Troy, and G.H. Theilen Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus Cancer Res 40 1980 3642 3651
7. H. Lutz, N.C. Pedersen, and G.H. Theilen Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies Am J Vet Res 44 1983 2054 2059
8. Hoover EA, Olsen RG, Hardy WD Jr, Schaller JP, Mathes LE, Cockerell GL. Biologic and immunologic response of cats to experimental infection with feline leukemia virus. Bibl Haematol 1975;October(43):180-3.
9. J.L. Rojko, and G.J. Kociba Pathogenesis of infection by the feline leukemia virus J Am Vet Med Assoc 199 1991 1305 1310
10. J.L. Rojko, E.A. Hoover, L.E. Mathes, R.G. Olsen, and J.P. Schaller Pathogenesis of experimental feline leukemia virus infection J Natl Cancer Inst 63 3 1979 759 768
11. W.D. Hardy Jr., P.W. Hess, E.G. MacEwen, A.J. McClelland, E.E. Zuckerman, and M. Essex Biology of feline leukemia virus in the natural environment Cancer Res 36 1976 582 588
12. J.N. Flynn, S.P. Dunham, V. Watson, and O. Jarrett Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection J Virol 76 5 2002 2306 2315
13. J.N. Flynn, L. Hanlon, and O. Jarrett Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes Immunology 101 1 2000 120 125
14. A.J. McClelland, W.D. Hardy, and E.E. Zuckerman Prognosis of healthy feline leukemia virus infected cats W.D. Hardy M. Essex McClelland Cancer research 1980 Elsevier Amsterdam 121 126
15. N.C. Pedersen, G. Theilen, M.A. Keane, L. Fairbanks, T. Mason, and B. Orser Studies of naturally transmitted feline leukemia virus infection Am J Vet Res 38 1977 1523 1531
16. H. Lutz, N.C. Pedersen, R. Durbin, and G.H. Theilen Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27 J Immunol Methods 56 1983 209 220
17. B.R. Madewell, and O. Jarrett Recovery of feline leukaemia virus from non-viraemic cats Vet Rec 112 1983 339 342
18. J.L. Rojko, E.A. Hoover, S.L. Quackenbush, and R.G. Olsen Reactivation of latent feline leukaemia virus infection Nature 298 1982 385 388
19. K.A. Hayes, J.L. Rojko, M.J. Tarr, P.J. Polas, R.G. Olsen, and L.E. Mathes Atypical localised viral expression in a cat with feline leukaemia Vet Rec 124 1989 344 346
20. A.M. Pacitti, O. Jarrett, and D. Hay Transmission of feline leukaemia virus in the milk of a non-viraemic cat Vet Rec 118 14 1986 381 384
21. R. Hofmann-Lehmann, J.B. Huder, S. Gruber, F. Boretti, B. Sigrist, and H. Lutz Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats J Gen Virol 82 Pt 7 2001 1589 1596
22. A.H. Sparkes Feline leukaemia virus and vaccination J Feline Med Surg 5 2 2003 97 100
23. A.H. Sparkes Feline leukaemia virus: a review of immunity and vaccination J Small Anim Pract 38 5 1997 187 194
24. O. Jarrett, and J.P. Ganiere Comparative-studies of the efficacy of a recombinant feline leukemia virus vaccine Vet Rec 138 1 1996 7 11
25. D.L. Hines, J.A. Cutting, D.L. Dietrich, and J.A. Walsh Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection J Am Vet Med Assoc 199 1991 1428 1430
26. E.A. Hoover, N.A. Perigo, S.L. Quackenbush, C.K. Mathiason-DuBard, J.M. Overbaugh, and W.S. Kloetzer Protection against feline leukemia virus infection by use of an inactivated virus vaccine J Am Vet Med Assoc 199 1991 1392 1401
27. S.M. York, and C.J. York Development of a whole killed feline leukemia virus vaccine J Am Vet Med Assoc 199 1991 1419 1422
28. I. Tizard, and E.P. Bass Evaluation of a killed, whole virion feline leukemia virus vaccine J Am Vet Med Assoc 199 1991 1410 1413
29. D.J. Marciani, C.R. Kensil, G.A. Beltz, C.H. Hung, J. Cronier, and A. Aubert Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats Vaccine 9 1991 89 96
30. H. Poulet, S. Brunet, C. Boularand, A.L. Guiot, V. Leroy, and J. Tartaglia Efficacy of a canarypox virus-vectored vaccine against feline leukaemia Vet Rec 153 5 2003 141 145
31. O. Jarrett, H.M. Laird, and D. Hay Determinants of the host range of feline leukaemia viruses J Gen Virol 20 1973 169 175
32. H. Lutz, P. Arnold, U. Hubscher, H. Egberink, N. Pedersen, and M.C. Horzinek Specificity assessment of feline T-lymphotropic lentivirus serology Zentralbl Veterinärmed (Part B) 35 1988 773 778
33. Feline leukemia vaccine (inactivated). In: Monograph of the European Pharmacopoeia Commission; 2005. p. 761.
34. R. Lehmann, M. Franchini, A. Aubert, C. Wolfensberger, J. Cronier, and H. Lutz Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine J Am Vet Med Assoc 199 1991 1446 1452
35. R. Tandon, V. Cattori, M.A. Gomes-Keller, M.L. Meli, M.C. Golder, H. Lutz, and R. Hofmann-Lehmann Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction J Virol Methods 130 2005 124 132
36. R.V. Pollock, and J.M. Scarlett Randomized blind trial of a commercial FeLV vaccine J Am Vet Med Assoc 196 1990 611 616
37. E.A. Hoover, J.I. Mullins, H.J. Chu, and T.L. Wasmoen Efficacy of an inactivated feline leukemia virus vaccine AIDS Res Hum Retroviruses 12 5 1996 379 383
38. A.N. Torres, C.K. Mathiason, and E.A. Hoover Re-examination of feline leukemia virus:host relationships using real-time PCR Virology 332 1 2005 272 283
39. R. Hofmann-Lehmann, E. Holznagel, A. Aubert, P. Ossent, M. Reinacher, and H. Lutz Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection Vet Immunol Immunopathol 46 1995 127 137
40. R. Hofmann-Lehmann, E. Holznagel, P. Ossent, and H. Lutz Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry and lymphocyte subsets Clin Diagn Lab Immunol 4 1 1997 33 42
41. M.G. Lewis, L.E. Mathes, and R.G. Olsen Protection against feline leukemia by vaccination with a subunit vaccine Infect Immun 34 1981 888 894
42. J.L. Rojko, E.A. Hoover, L.E. Mathes, S. Krakowka, and R.G. Olsen Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection Cancer Res 39 1979 3789 3791
43. A.M. Legendre, D.M. Hawks, R. Sebring, B. Rohrbach, L. Chavez, and H.J. Chu Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure J Am Vet Med Assoc 199 1991 1456 1462
44. E.A. Hoover, L.E. Mathes, J.L. Rojko, J.P. Schaller, and R.G. Olsen Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens Am J Vet Res 39 1978 1877 1880
45. P. Klenerman, H. Hengartner, and R.M. Zinkernagel A non-retroviral RNA virus persists in DNA form Nature 390 1997 298 301